Bart Filius
Director/Board Member chez PROQR THERAPEUTICS N.V.
Fortune : - $ au 31/03/2024
Provenance du réseau au premier degré de Bart Filius
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
INSEAD
110
| College/University | Other Consumer Services | 110 |
29
| Public Company | Biotechnology | 29 |
Nyenrode Business Universiteit
16
| College/University | Other Consumer Services | 16 |
| Public Company | Pharmaceuticals: Major | 16 | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom.
4
| Subsidiary | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bart Filius via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer Treasurer | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| SIEMENS AG | Industrial Machinery | Treasurer Sales & Marketing | |
| SANOFI | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Guaranty Trust Bank Ltd. (Nigeria)
 Guaranty Trust Bank Ltd. (Nigeria) Major BanksFinance Guaranty Trust Bank Ltd. engages in the provision of commercial banking solutions. Its services include current accounts, deposits, overdrafts, loans and other credit facilities, foreign currency, and providing derivative products. It operates through the following segments: Corporate Banking, Retail Banking, Commercial Banking, Small and Medium Enterprises (SME) Banking, and Public Sector Banking. The Corporate Banking segment offers services in large corporate customers and blue chips. The Retail Banking segment comprises private banking services, private customer current accounts, savings deposits, investment savings products, custody, credit and debit cards, customer loans, and mortgages. The Commercial Banking segment focuses on the mid-size and fledgling corporate customers. The SME Banking segment consists of small and medium-size enterprises and ventures. The Public Sector Banking segment provides services for government ministries, departments, and agencies. The company was founded by Afolabi Aiyeola and Olutayo Aderinokun on July 20, 1990 and is headquartered in Lagos, Nigeria. | Major Banks | Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Twente | College/University | Graduate Degree Corporate Officer/Principal | |
| Virginia Polytechnic Institute & State University | College/University | Graduate Degree Graduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Graduate Degree | |
| University of Amsterdam | College/University | Graduate Degree Graduate Degree | |
| London School of Economics & Political Science | College/University | Undergraduate Degree Graduate Degree | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Nottingham | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Leiden | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| University of Utrecht | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Bocconi | College/University | Undergraduate Degree Undergraduate Degree | |
| Ghent University | College/University | Graduate Degree Graduate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| École Centrale Paris | College/University | Graduate Degree Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Director/Board Member | |
Aescap Venture Management BV
 Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Investment Managers | Founder Private Equity Investor | |
| King's College London | College/University | Undergraduate Degree Undergraduate Degree | |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Leadspace, Inc.
 Leadspace, Inc. Internet Software/ServicesTechnology Services Leadspace, Inc. develops an internet search engine based on semantic technologies. It offers audience management platform that enables users to search, save and organize, retrieve and use, and share the information. The company was founded by Amnon Mishor and Yaron Karasik in 2007 and is headquartered in San Francisco, CA. | Internet Software/Services | Chairman Chief Executive Officer | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member Chief Executive Officer | |
Flatiron Health, Inc.
 Flatiron Health, Inc. Packaged SoftwareTechnology Services Flatiron Health, Inc. develops health care technology. Its OncologyCloud platform allows cancer centers, physicians and life science companies to gain actionable insights from clinical, practice management and billing data. The firm's software platform accelerates personalized medicine and research by applying advanced analytics to electronic patient care data documented by physicians. The company was founded by Nathaniel S. Turner and Zachary W. Weinberg in 2012 and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
Impatients NV
 Impatients NV Miscellaneous Commercial ServicesCommercial Services Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom. | Miscellaneous Commercial Services | Founder Chairman | |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chairman | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 17 |
| Royaume-Uni | 11 |
| Pays-Bas | 9 |
| Belgique | 5 |
| France | 4 |
Sectorielle
| Health Technology | 20 |
| Consumer Services | 19 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 587 |
| Corporate Officer/Principal | 208 |
| Independent Dir/Board Member | 103 |
| Chief Executive Officer | 98 |
| Chairman | 90 |
Relations les plus connectées
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Jürgen Eckhardt | 34 |
| Johan Peter van de Steen | 33 |
| J. Manuel Jordão Sérvulo Rodrigues | 33 |
| Jayesh Ramesh Patel | 29 |
| Vicki Sato | 28 |
| Aleksandr Vadimovich Izosimov | 27 |
| Paul Smith | 27 |
| Dominik Asam | 26 |
| Eva Berneke | 25 |
| Alison Lawton | 24 |
| Hadar Bo Erik Cars | 23 |
| Lars Bjørn Thoresen | 23 |
| Jérôme Contamine | 23 |
| James Shannon | 22 |
- Bourse
- Insiders
- Bart Filius
- Connexions Sociétés
